MRKR
Price
$1.77
Change
+$0.25 (+16.45%)
Updated
Jun 6 closing price
Capitalization
18.95M
XNCR
Price
$9.65
Change
+$0.53 (+5.81%)
Updated
Jun 6 closing price
Capitalization
686.8M
51 days until earnings call
Interact to see
Advertisement

MRKR vs XNCR

Header iconMRKR vs XNCR Comparison
Open Charts MRKR vs XNCRBanner chart's image
Marker Therapeutics
Price$1.77
Change+$0.25 (+16.45%)
Volume$166.54K
Capitalization18.95M
Xencor
Price$9.65
Change+$0.53 (+5.81%)
Volume$526.02K
Capitalization686.8M
MRKR vs XNCR Comparison Chart
Loading...
MRKR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XNCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MRKR vs. XNCR commentary
Jun 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MRKR is a Buy and XNCR is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 09, 2025
Stock price -- (MRKR: $1.10 vs. XNCR: $7.55)
Brand notoriety: MRKR and XNCR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MRKR: 105% vs. XNCR: 59%
Market capitalization -- MRKR: $18.95M vs. XNCR: $686.8M
MRKR [@Biotechnology] is valued at $18.95M. XNCR’s [@Biotechnology] market capitalization is $686.8M. The market cap for tickers in the [@Biotechnology] industry ranges from $334.5B to $0. The average market capitalization across the [@Biotechnology] industry is $2.25B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MRKR’s FA Score shows that 1 FA rating(s) are green whileXNCR’s FA Score has 1 green FA rating(s).

  • MRKR’s FA Score: 1 green, 4 red.
  • XNCR’s FA Score: 1 green, 4 red.
According to our system of comparison, both MRKR and XNCR are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MRKR’s TA Score shows that 4 TA indicator(s) are bullish while XNCR’s TA Score has 4 bullish TA indicator(s).

  • MRKR’s TA Score: 4 bullish, 4 bearish.
  • XNCR’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both MRKR and XNCR are a good buy in the short-term.

Price Growth

MRKR (@Biotechnology) experienced а 0.00% price change this week, while XNCR (@Biotechnology) price change was +0.40% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.11%. For the same industry, the average monthly price growth was +10.01%, and the average quarterly price growth was -2.16%.

Reported Earning Dates

XNCR is expected to report earnings on Jul 30, 2025.

Industries' Descriptions

@Biotechnology (+4.11% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
XNCR($687M) has a higher market cap than MRKR($19M). MRKR (-64.630) and XNCR (-67.145) have similar YTD gains . MRKR has higher annual earnings (EBITDA): -10.19M vs. XNCR (-186.17M). XNCR has more cash in the bank: 498M vs. MRKR (9M). MRKR has less debt than XNCR: MRKR (0) vs XNCR (232M). XNCR has higher revenues than MRKR: XNCR (110M) vs MRKR (0).
MRKRXNCRMRKR / XNCR
Capitalization19M687M3%
EBITDA-10.19M-186.17M5%
Gain YTD-64.630-67.14596%
P/E RatioN/AN/A-
Revenue0110M-
Total Cash9M498M2%
Total Debt0232M-
FUNDAMENTALS RATINGS
MRKR vs XNCR: Fundamental Ratings
MRKR
XNCR
OUTLOOK RATING
1..100
104
VALUATION
overvalued / fair valued / undervalued
1..100
15
Undervalued
79
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9897
PRICE GROWTH RATING
1..100
9195
P/E GROWTH RATING
1..100
1004
SEASONALITY SCORE
1..100
3n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

MRKR's Valuation (15) in the Other Consumer Services industry is somewhat better than the same rating for XNCR (79) in the Biotechnology industry. This means that MRKR’s stock grew somewhat faster than XNCR’s over the last 12 months.

MRKR's Profit vs Risk Rating (100) in the Other Consumer Services industry is in the same range as XNCR (100) in the Biotechnology industry. This means that MRKR’s stock grew similarly to XNCR’s over the last 12 months.

XNCR's SMR Rating (97) in the Biotechnology industry is in the same range as MRKR (98) in the Other Consumer Services industry. This means that XNCR’s stock grew similarly to MRKR’s over the last 12 months.

MRKR's Price Growth Rating (91) in the Other Consumer Services industry is in the same range as XNCR (95) in the Biotechnology industry. This means that MRKR’s stock grew similarly to XNCR’s over the last 12 months.

XNCR's P/E Growth Rating (4) in the Biotechnology industry is significantly better than the same rating for MRKR (100) in the Other Consumer Services industry. This means that XNCR’s stock grew significantly faster than MRKR’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
MRKRXNCR
RSI
ODDS (%)
N/A
Bullish Trend 13 days ago
64%
Stochastic
ODDS (%)
Bullish Trend 13 days ago
81%
Bullish Trend 13 days ago
73%
Momentum
ODDS (%)
Bearish Trend 13 days ago
90%
Bearish Trend 13 days ago
77%
MACD
ODDS (%)
Bullish Trend 13 days ago
71%
Bearish Trend 13 days ago
79%
TrendWeek
ODDS (%)
Bearish Trend 13 days ago
90%
Bearish Trend 13 days ago
83%
TrendMonth
ODDS (%)
Bearish Trend 13 days ago
90%
Bearish Trend 13 days ago
84%
Advances
ODDS (%)
Bullish Trend 14 days ago
80%
Bullish Trend 26 days ago
71%
Declines
ODDS (%)
Bearish Trend 29 days ago
90%
Bearish Trend about 1 month ago
81%
BollingerBands
ODDS (%)
Bearish Trend 14 days ago
84%
Bullish Trend 13 days ago
76%
Aroon
ODDS (%)
Bullish Trend 13 days ago
76%
Bearish Trend 13 days ago
81%
View a ticker or compare two or three
Interact to see
Advertisement
MRKR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XNCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AAPL200.420.21
+0.10%
Apple
SPY587.73-3.42
-0.58%
SPDR® S&P 500® ETF
BTC.X107802.330000-1192.312500
-1.09%
Bitcoin cryptocurrency
TSLA356.90-5.99
-1.65%
Tesla
GME31.21-3.80
-10.85%
GameStop Corp

MRKR and

Correlation & Price change

A.I.dvisor tells us that MRKR and CGON have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MRKR and CGON's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MRKR
1D Price
Change %
MRKR100%
-4.35%
CGON - MRKR
32%
Poorly correlated
-0.94%
RCKT - MRKR
31%
Poorly correlated
+6.44%
EYPT - MRKR
30%
Poorly correlated
+18.12%
PMVP - MRKR
30%
Poorly correlated
+0.01%
XNCR - MRKR
30%
Poorly correlated
-2.58%
More

XNCR and

Correlation & Price change

A.I.dvisor indicates that over the last year, XNCR has been loosely correlated with RCKT. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if XNCR jumps, then RCKT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XNCR
1D Price
Change %
XNCR100%
-2.58%
RCKT - XNCR
59%
Loosely correlated
+6.44%
CRNX - XNCR
58%
Loosely correlated
+1.39%
ERAS - XNCR
57%
Loosely correlated
+1.85%
BEAM - XNCR
57%
Loosely correlated
-0.88%
BCYC - XNCR
54%
Loosely correlated
+2.12%
More